DNA Topoisomerases in Cancer Therapy: Present and Future
Author:   Toshiwo Andoh
Publisher:   Springer-Verlag New York Inc.
Edition:   Softcover reprint of the original 1st ed. 2003
ISBN:  

9781461349419


Pages:   202
Publication Date:   23 October 2012
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $290.37 Quantity:  
Add to Cart

Share |

DNA Topoisomerases in Cancer Therapy: Present and Future


Add your own review!

Overview

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

Full Product Details

Author:   Toshiwo Andoh
Publisher:   Springer-Verlag New York Inc.
Imprint:   Springer-Verlag New York Inc.
Edition:   Softcover reprint of the original 1st ed. 2003
Dimensions:   Width: 15.50cm , Height: 1.20cm , Length: 23.50cm
Weight:   0.343kg
ISBN:  

9781461349419


ISBN 10:   1461349419
Pages:   202
Publication Date:   23 October 2012
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1 Reflections on an accidental discovery.- 2 Mechanisms of topoisomerase I inhibition by anticancer drugs.- 3 Mechanism of action of topoisomerase II-targeted anticancer drugs.- 4 Degradation of topoisomerase cleavable complexes.- 5 Yeast as a model system in the analysis of DNA topoisomerase I poisons.- 6 Understanding the action of drugs targeting TOP2: Yeast based systems for unraveling drug mechanisms.- 7 Cellular resistance to DNA topoisomerase I-targeting drugs.- 8 Development of new topoisomerase I-targeting compounds as candidate anticancer drugs.- 9 Development of new topoisomerase II-targeting compounds as candidate anticancer drugs.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

JRG25

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now